An Educational Microlearning Snapshot Activity
Retinal Therapy Revolution: Managing Retinal Disease with Emerging and Targeted Therapies
A Focus on Gene Therapy
This educational Microlearning Snapshot enduring activity focuses on the importance of genes in the pathogenesis of inherited and acquired retinal diseases and how they can be leveraged in gene therapy for the management of various retinal diseases. Additional considerations regarding risk/benefit profile, durability, feasibility and application as well as emerging advances in anti-vascular endothelial growth factor (anti-VEGF) treatment are also explored for impact on overcoming barriers related to treatment burden and adherence.
IMMERSIVE SIMULATION EXPERIENCE
Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization
Incorporating Clinical Trials Data into the Management of DR, AMD, RVO, mCNV, and PCV
This engaging activity is designed for ophthalmology residents and retina fellows to improve familiarity with new and emerging clinical trial data for retinal vascular diseases. Through better understanding of clinical trial structures, efficacy and safety outcomes for studied anti-VEGF agents, this data can be utilized to enhance the creation of evidence-based treatment plans for patients with DR, AMD, RVO, mCNV, and PCV.
A Virtual Reality Learning Experience: Integrating GLP-1 Receptor Agonists into T2DM Practice—Why, When, and How
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.